Trials / Conditions / Oligometastatic Prostate Cancer (OMPC)
Oligometastatic Prostate Cancer (OMPC)
4 registered clinical trials studyying Oligometastatic Prostate Cancer (OMPC) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC NCT07090148 | University of Wisconsin, Madison | Phase 1 |
| Not Yet Recruiting | HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bon NCT06978296 | Institut Cancerologie de l'Ouest | N/A |
| Not Yet Recruiting | Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) NCT07237399 | University Hospital, Ghent | — |
| Recruiting | An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414 | Novartis Pharmaceuticals | Phase 3 |